0

Chronic Obstructive Airway Disease Collection
 1-20 of 29 Articles
ACP Journal Club |  16 June 2015
Review: Pulmonary rehabilitation improves health-related QoL and exercise capacity more than usual care in COPD
Christine F. McDonald, MBBS (Hons), PhD
Ann Intern Med. 2015;162(12):JC4. doi:10.7326/ACPJC-2015-162-12-004
ACP Journal Club |  17 March 2015
For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2015;162(6):JC5. doi:10.7326/ACPJC-2015-162-6-005
ACP Journal Club |  17 March 2015
Review: Systemic corticosteroids reduce treatment failure but increase hyperglycemia in COPD exacerbations
Paul Jones, MBBS
Ann Intern Med. 2015;162(6):JC6. doi:10.7326/ACPJC-2015-162-6-006
ACP Journal Club |  17 March 2015
Review: ≤ 7 and > 7 days of systemic corticosteroids do not differ for efficacy in COPD exacerbations
Paul Jones, MBBS
Ann Intern Med. 2015;162(6):JC7. doi:10.7326/ACPJC-2015-162-6-007
ACP Journal Club |  19 August 2014
Review: In COPD, fluticasone or budesonide increases serious pneumonia but not mortality
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2014;161(4):JC8. doi:10.7326/0003-4819-161-4-201408190-02008
ACP Journal Club |  15 April 2014
Review: Exercise programs after pulmonary rehabilitation preserve short-term exercise capacity in COPD
Yves Lacasse, MD, MSc, FRCPC
Ann Intern Med. 2014;160(8):JC4. doi:10.7326/0003-4819-160-8-201404150-02004
ACP Journal Club |  17 September 2013
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation
Diego J. Maselli, MD; Jay I. Peters, MD
Ann Intern Med. 2013;159(6):JC5. doi:10.7326/0003-4819-159-6-201309170-02005
ACP Journal Club |  18 June 2013
Review: Inhaled medications vary substantively in their effects on mortality in COPD
Shirin Shafazand, MD, MS, FCCP, FAASM
Ann Intern Med. 2013;158(12):JC2. doi:10.7326/0003-4819-158-12-201306180-02002
ACP Journal Club |  21 May 2013
Review: Nutritional supplementation has uncertain effects on patient-important outcomes in COPD
Christine McDonald, MBBS (Hons), FRACP, PhD, FCCP
Ann Intern Med. 2013;158(10):JC5. doi:10.7326/0003-4819-158-10-201305210-02005
ACP Journal Club |  16 April 2013
Review: Antibiotics reduce treatment failure in acute chronic obstructive pulmonary disease exacerbations
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2013;158(8):JC5. doi:10.7326/0003-4819-158-8-201304160-02005
ACP Journal Club |  19 March 2013
Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD
Sandra G. Adams, MD, MS; Jay I. Peters, MD
Ann Intern Med. 2013;158(6):JC3. doi:10.7326/0003-4819-158-6-201303190-02003
ACP Journal Club |  19 February 2013
Review: Corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD
Shawn D. Aaron, MD
Ann Intern Med. 2013;158(4):JC9. doi:10.7326/0003-4819-158-4-201302190-02009
ACP Journal Club |  20 March 2012
Review: Long-term use of inhaled corticosteroids increases fracture risk in COPD
Joram S. Seggev, MD, FAAAAI, FACAAI, FACP
Ann Intern Med. 2012;156(6):JC3-7. doi:10.7326/0003-4819-156-6-201202210-02007
ACP Journal Club |  21 February 2012
Prior use of inhaled corticosteroids was associated with less mortality in elders with COPD and pneumonia
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2012;156(4):JC2-12. doi:10.7326/0003-4819-156-4-201202210-02012
ACP Journal Club |  17 January 2012
Azithromycin once daily for 1 year reduced acute COPD exacerbations
Jay Peters, MD; Antonio Anzueto, MD
Ann Intern Med. 2012;156(2):JC1-10. doi:10.7326/0003-4819-156-2-201201170-02010
ACP Journal Club |  18 October 2011
Review: Tiotropium mist inhaler increases mortality in chronic obstructive pulmonary disease
Brian J. Lipworth, MD
Ann Intern Med. 2011;155(8):JC4-6. doi:10.7326/0003-4819-155-8-201110180-02006
ACP Journal Club |  20 September 2011
Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD
Felix S.F. Ram, PhD, Clinical Pharmacologist
Ann Intern Med. 2011;155(6):JC3-2. doi:10.7326/0003-4819-155-6-201109200-02002
ACP Journal Club |  19 July 2011
Tiotropium reduced exacerbations more than salmeterol in moderate-to-very severe COPD
Peter Wark, BMed, FRACp, PhD
Ann Intern Med. 2011;155(2):JC1-3. doi:10.7326/0003-4819-155-2-201107190-02003
ACP Journal Club |  15 March 2011
A COPD disease management program reduced a composite of hospitalizations or emergency department visits
Kevin Park, MD; Richard A. Robbins, MD
Ann Intern Med. 2011;154(6):JC3-5. doi:10.7326/0003-4819-154-6-201103150-02005
ACP Journal Club |  20 July 2010
Review: Tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2010;153(2):JC1-2. doi:10.7326/0003-4819-153-2-201007200-02002
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)